We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Florian Lordick

Florian Lordick MD, PhD

Director and Professor of Oncology, University Cancer Center Leipzig, Germany

Dr. Florian Lordick is Director and Professor of Oncology of the University Cancer Center Leipzig, Germany. 

His scientific focus is clinical and translational research in gastrointestinal cancer, the optimization of multimodal and personalized cancer care, and palliative and supportive care; he has authored and co-authored more than 250 peer-reviewed articles. He is a member of the editorial board of several international journals, including Annals of Oncology, Cancer Treatment Reviews, and Gastric Cancer, and serves as a scientific advisor and reviewer for various medical journals such as The New England Journal of Medicine, The Lancet, The Lancet Oncology, and the European Journal of Cancer

Dr. Lordick is on the board of directors and serves as secretary of the German Cancer Society (DKG), for which he is also chairman of the palliative care working group. He is a member of the European Society for Medical Oncology (ESMO), the European Organization of Research and Treatment of Cancer (EORTC), and the American Society of Clinical Oncology (ASCO), among other professional organizations. He is the president elect of the International Gastric Cancer Association and has been nominated to the European School of Oncology (ESO) core faculty. 

Dr. Lordick received his medical training at the Universities of Regensburg, Munich, and Lausanne. He completed his residency in internal medicine and oncology/hematology at the Technical University of Munich.